These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25618172)

  • 21. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
    Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
    J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sudden cardiac death associated with methylone use.
    Carbone PN; Carbone DL; Carstairs SD; Luzi SA
    Am J Forensic Med Pathol; 2013 Mar; 34(1):26-8. PubMed ID: 23403480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of synthetic phenethylamine street drugs using direct sample analysis coupled to accurate mass time of flight mass spectrometry.
    McGonigal MK; Wilhide JA; Smith PB; Elliott NM; Dorman FL
    Forensic Sci Int; 2017 Jun; 275():83-89. PubMed ID: 28329723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and characterization of emerging psychoactive substances by ion mobility spectrometry.
    Armenta S; Garrigues S; de la Guardia M; Brassier J; Alcalà M; Blanco M; Perez-Alfonso C; Galipienso N
    Drug Test Anal; 2015 Apr; 7(4):280-9. PubMed ID: 24935207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 3-year review of new psychoactive substances in casework.
    Elliott S; Evans J
    Forensic Sci Int; 2014 Oct; 243():55-60. PubMed ID: 24810679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines.
    Kerrigan S; Mellon MB; Banuelos S; Arndt C
    J Anal Toxicol; 2011 Sep; 35(7):444-51. PubMed ID: 21871153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis.
    Mercolini L; Protti M
    J Pharm Biomed Anal; 2016 Oct; 130():202-219. PubMed ID: 27424495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug Recognition Evaluation and Chemical Confirmation of a 25C-NBOMe-Impaired Driver.
    Rajotte JW; Palmentier JFP; Wallage HR
    J Forensic Sci; 2017 Sep; 62(5):1410-1413. PubMed ID: 28261791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous detection of ten psychedelic phenethylamines in urine by gas chromatography-mass spectrometry.
    Kerrigan S; Banuelos S; Perrella L; Hardy B
    J Anal Toxicol; 2011 Sep; 35(7):459-69. PubMed ID: 21871155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.
    Rojek S; Kłys M; Strona M; Maciów M; Kula K
    Forensic Sci Int; 2012 Oct; 222(1-3):e1-6. PubMed ID: 22648055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
    Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry.
    Kerrigan S; Mott A; Jatzlau B; Ortiz F; Perrella L; Martin S; Bryand K
    J Forensic Sci; 2014 Jan; 59(1):175-83. PubMed ID: 24313279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs).
    Rösner P; Quednow B; Girreser U; Junge T
    Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermal Degradation of Synthetic Cathinones: Implications for Forensic Toxicology.
    Kerrigan S; Savage M; Cavazos C; Bella P
    J Anal Toxicol; 2016; 40(1):1-11. PubMed ID: 26294756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
    Habrdova V; Peters FT; Theobald DS; Maurer HH
    J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].
    Zawilska JB; Słomiak K; Wasiak M; Woźniak P; Massalski M; Krupa E; Wojcieszak JŁ
    Przegl Lek; 2013; 70(6):386-91. PubMed ID: 24052975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.